Amphastar Pharmaceuticals (AMPH)

[Phaeton]

I went back and listened to the Amphstar call again. They said that they had 9 billion in the pipeline on generic products using their inhalation side of their business. They particularly stated that they were working on PARTICULE ENGINEERING of complex molecules. They view their inhalation side of the business with a higher value. That Amphstar would do the science side and that a Pharm partner would do the sales and marketing side. Makes me wonder if they are going to use the Technosphere on some generic drugs. I would encourage you go listen to the call and give your opinion. I found the call interesting. this part was in the last 7 or 8 mins of the call. One of the generics mentioned was Advir